The U.S. healthcare system spends enormous resources treating conditions that, in many cases, poor nutrition helped create. Diet-related chronic diseases such as diabetes, heart failure, chronic kidney disease, and obesity drive a disproportionate share of total healthcare costs and represent some of the highest-cost members across Medicaid, Medicare Advantage, and commercial populations.
A relatively small group of high-risk members drives a large percentage of total spending. That is not new. What is new is how little progress most organizations have made in addressing one of the most direct drivers of that cost: nutrition.
As medical trend continues to be shaped by these high-cost populations, interventions that meaningfully change outcomes for this group will have an outsized impact on overall cost and premium pressure.
Yet for most patients, nutrition is still treated as an afterthought. It is addressed with a brief counseling note, a handout, or a recommendation that assumes patients have the time, resources, and knowledge to translate advice into action. Most do not.
That gap is no longer acceptable in a value-based environment.
Food as medicine, delivered through medically tailored meals and dietitian support, is emerging as a true clinical intervention. The question is no longer whether food matters. The question is whether the system is willing to treat it as care.
The Data Is Clear. Execution Has Been the Constraint.
A study published in the Journal of the American Medical Association Internal Medicine found that medically tailored meal programs were associated with 16% fewer hospitalizations, 49% fewer skilled nursing facility admissions, and significantly lower total healthcare costs compared to similar patients who did not receive the intervention.
In high-risk populations, those are not incremental improvements. They are material to the cost structure.
Separate modeling from researchers at Tufts University estimates that scaling medically tailored meals nationally for patients with diet-sensitive conditions could generate approximately $23 billion in annual healthcare savings. That level of impact is rare in healthcare.
Additional research across heart failure, chronic kidney disease, and diabetes populations continues to show reductions in emergency department usage and slower disease progression. These are two of the most expensive drivers in any high-acuity population.
The industry has not lacked evidence. It has lacked a way to operationalize nutrition at scale.
That is what is changing.
Medicaid Is Leading. Others Will Follow.
Medicaid beneficiaries sit at the intersection of high rates of diet-related chronic disease, elevated food insecurity, and significant barriers to accessing consistent, appropriate nutrition. They are also among the highest-cost members in any managed care population.
This makes Medicaid the most urgent and logical place to deploy medically tailored meals at scale. It is also where the market is moving fastest.
Section 1115 waivers have created a pathway to fund nutrition as a health-related social need, and states such as North Carolina, California, New York, and Massachusetts are actively integrating food-based interventions into their care models. What was once a niche pilot category is now being implemented at scale across multiple states and national plans.
While Medicaid is leading, the same underlying dynamic exists in Medicare Advantage and increasingly in commercial populations. Chronic disease is rising, nutrition is a primary driver, and traditional care management alone is not bending the cost curve.
Most Plans Cover Nutrition. Very Few Deliver It.
Most health plans already offer some form of nutrition benefit. That is not the issue.
The issue is that these benefits rarely change behavior, improve outcomes, or reduce usage in a measurable way.
Medically tailored meals are different because they function as clinical infrastructure. They can be prescribed based on diagnosis, delivered through repeatable workflows, and measured directly against claims outcomes.
That changes the conversation.
In a value-based model, interventions that cannot be operationalized and measured do not scale. Nutrition has historically fallen into that category. Medically tailored meals move it out of it.
What Happens When Nutrition Is Delivered as Care
In working with high-risk populations across Medicaid, Medicare, and commercial lines of business managing conditions such as type 2 diabetes, hypertension, irritable bowel syndrome (IBS), and kidney disease, a consistent pattern emerges. When nutrition is delivered in a way that is clinically appropriate, convenient, and paired with dietitian support, engagement increases significantly. More importantly, usage begins to shift.
In large Medicaid populations, meals often serve as the front door to broader care management. They create immediate engagement and make it easier to connect members to additional services. Within the first few months, changes in usage patterns begin to appear, particularly among members with poorly controlled chronic conditions.
This is not about sending food. It is about delivering a clinical input that most high-risk patients have never had consistent access to, and measuring what happens when they do.
A Strategic Choice, Not a Pilot Decision
For payers evaluating their value-based care strategies, the question is not whether nutrition affects outcomes. That is already established.
The real question is whether nutrition will be treated as a core component of care delivery or remain a peripheral benefit that produces limited impact.
Medically tailored meals address clinical risk, social determinants, member engagement, and total cost of care in a single intervention. That combination is rare. It is also increasingly necessary as cost pressures and quality expectations rise across all lines of business.
Over the next three to five years, nutrition will move from a supplemental benefit to a standard component of high-risk care strategies, much like care management did a decade ago.
Plans that move early and operationalize nutrition as care will build a measurable advantage in managing their highest-cost populations.
Plans that do not will continue to manage the downstream consequences.
Ignoring food is not a neutral decision. It is a financial one.
